Rituximab and ABVD for Hodgkin's Patients
Clinical trial NCT00504504 · COMPLETED
Trial details
- NCT number
- NCT00504504
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-03-01
- Primary completion
- 2012-03-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.